Life sciences briefing: Wednesday, Nov. 7, 2007
Featured companies: Aryx Therapeutics, BioForm Medical, Health Market Science, Hypobaric Therapeutics, Mobile Medical International
UPDATED: Expanded items on BioForm, Aryx, Hypobaric and Mobile Medical.
Medical aethetics co. BioForm Medical prices IPO below range, raises up to $92M — BioForm Medical, a wrinkle-treatment maker based in San Mateo, Calif., priced its IPO below its expected range of $9 to $11 a share, reducing its maximum take from the offering to $92 million from $127 million. (See our earlier coverage here… Continue Reading
Life sciences briefing: Monday, Oct. 22, 2007
Featured companies: Ablynx, Avant Immunotherapeutics, BioForm Medical, Celldex Therapeutics, Genomas, High-Throughput Genomics, Orchid Cellmark, ReliaGene Technologies, SarCode, TransMolecular, VisEn Medical
UPDATED: Expanded items on SarCode, Celldex/Avant and Ablynx.
UPDATE REDUX: Added items on BioForm Medical, High-Throughput Genomics and Orchid Cellmark/ReliaGene.
San Francisco’s SarCode draws down $7M for inflammation drugs — The two-year-old startup drew down $7 million as part of a $25 million first funding round the company arranged last December, VentureWire reports (subscription required). Investors in that round included Alta… Continue Reading
Life sciences briefing: Tuesday, Aug. 21, 2007
(UPDATED at 7:40pm PT: See below.)
Featured companies: Adnexus Therapeutics, BioForm Medical, Confirma, Cardiovascular Systems, Mirabilis Medica, Neuromed Pharmaceuticals, PlaCor, Seno Medical Instruments, Vibrynt
BioForm Medical files $115M IPO for “medical aesthetics” — BioForm Medical, a San Mateo, Calif., developer of wrinkle fillers and other products for cosmetic procedures, filed to raise $115 million in an initial offering. BioForm’s major customers are plastic surgeons and dermatologists.
BioForm, however, takes pains to describe itself differently on its Web site…. Continue Reading